Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Achieve Life Sciences Inc (ACHV)

Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 147,533
  • Shares Outstanding, K 34,390
  • Annual Sales, $ 0 K
  • Annual Income, $ -29,820 K
  • EBIT $ -31 M
  • EBITDA $ -31 M
  • 60-Month Beta 1.57
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.74

Options Overview Details

View History
  • Implied Volatility 121.15% ( +22.09%)
  • Historical Volatility 41.38%
  • IV Percentile 65%
  • IV Rank 36.25%
  • IV High 272.02% on 04/22/24
  • IV Low 35.37% on 06/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 31
  • Volume Avg (30-Day) 82
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 16,086
  • Open Int (30-Day) 15,677

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.30
  • Number of Estimates 3
  • High Estimate -0.20
  • Low Estimate -0.39
  • Prior Year -0.26
  • Growth Rate Est. (year over year) -15.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.12 +4.13%
on 11/18/24
5.31 -19.21%
on 11/06/24
-0.60 (-12.27%)
since 10/22/24
3-Month
4.10 +4.63%
on 09/06/24
5.31 -19.21%
on 11/06/24
-0.12 (-2.61%)
since 08/22/24
52-Week
3.03 +41.58%
on 12/12/23
5.98 -28.26%
on 11/28/23
-0.87 (-16.86%)
since 11/22/23

Most Recent Stories

More News
Achieve Life Sciences to Participate in Upcoming Investor Conferences in London and New York

Achieve Life Sciences announced CEO participation in two investor conferences regarding cytisinicline's development for nicotine dependence treatment.Quiver AI SummaryAchieve Life Sciences, Inc., a late-stage...

ACHV : 4.29 (-0.92%)
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

ACHV : 4.29 (-0.92%)
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

ACHV : 4.29 (-0.92%)
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024

ACHV : 4.29 (-0.92%)
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting

ACHV : 4.29 (-0.92%)
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline

ACHV : 4.29 (-0.92%)
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting

ACHV : 4.29 (-0.92%)
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022

SEATTLE and VANCOUVER, British Columbia, July 28, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical...

ACHV : 4.29 (-0.92%)
Achieve Life Sciences Announces Granting of New Hire Inducement Awards

SEATTLE and VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...

ACHV : 4.29 (-0.92%)
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference

SEATTLE and VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical...

ACHV : 4.29 (-0.92%)

Business Summary

Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc.,...

See More

Key Turning Points

3rd Resistance Point 4.48
2nd Resistance Point 4.41
1st Resistance Point 4.35
Last Price 4.29
1st Support Level 4.22
2nd Support Level 4.15
3rd Support Level 4.09

See More

52-Week High 5.98
Fibonacci 61.8% 4.85
Fibonacci 50% 4.51
Last Price 4.29
Fibonacci 38.2% 4.16
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar